Clinical Trial Update: Antenatal Magnesium Sulphate in High-Risk Preterm Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antenatal magnesium sulfate in high-risk preterm pregnancies is currently recruiting, with cerebral palsy as a related condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Cairo University | Conditions: Cerebral Palsy, Magnesium Sulfate Overdose | Phase 3 | Status: RECRUITING